Article Text

Download PDFPDF

AB0357 Sexuality in women with rheumatoid arthritis - results of a survey
  1. R Puchner1,
  2. J Sautner2,
  3. J Gruber3,
  4. A Trenkler4,
  5. E Bragagna5,
  6. G Eberl6,
  7. A Alkin7,
  8. H Pieringer8
  1. 1Rheumatologist in private practice Wels, Wels
  2. 2Lower Austrian State Hospital, Stockerau, Stockerau
  3. 3Medical University of Innsbruck, Innsbruck
  4. 4Elisabethinen Hospital Linz, Linz
  5. 5Specialist in Sexual Medicine in private practice Vienna, Vienna
  6. 6Klinikum Malcherhof Baden, Baden bei Wien
  7. 7Centre of Excellence in Medicine Linz
  8. 82nd Department of Medicine, General Hospital Linz and Faculty of Medicine, Johannes Kepler University Linz, Linz, Austria


Background Diseases such as rheumatoid arthritis (RA) are distinguished by their chronic and progressive characteristics; they may lead to premature loss of joint function and constitute major social, economic and health burdens. Rheumatic diseases may affect all aspects of life including patients' sexuality.

Objectives The objective of the study was to evaluate the impact of RA on women's sexuality regarding sexual motivation, activity, and satisfaction and to assess the correlation of disease related physical impairment within sexual functioning.

Methods A group of rheumatologists, a sociologist and a specialist in sexual medicine initiated a substantial survey, including standardised questionnaires. The items asked were assessments of disease activity with the Clinical Disease Activity Index (CDAI) and measurements of illness and medically induced changes in sexual functioning with the Changes in Sexual Functioning Questionnaire-short form (CSFQ-14). Levels of depression were evaluated with the Beck Depression Inventory FastScreen (BDI FastScreen) and to establish disability the Health assessment questionnaire (HAQ) was used. Further questions were concerning demographic and health related data such as comorbidities, medication, alcohol and smoking habits.

Results 319 questionnaires were distributed to RA-patients and 319 to healthy controls (HCOs). 235 questionnaires from patients (73, 7%) and 180 HCO-questionnaires (58, 8%) were sent back.

Women with RA had a significantly lower CSRQ Score than HCOs. 48% of the patients had a total CSFQ score of ≤41, which is defined as an indicator of sexual dysfunction. However, only 14% of the healthy respondents scored similarly.

29.3% of the surveyed patients were in remission, 45.1% in low disease activity, 18.9% in a moderate disease activity and 6.8% in high disease activity. There was no relationship between CDAI and CSFQ.

Age and level of education were the most important demographic parameters connected with sexual dysfunction. There was also a moderate and significant relationship between depression and sexual dysfunction.

A significant correlation between the HAQ index and the level of sexual dysfunction was to be observed.

Conclusions Due to the lack of substantive surveys in this field, we tried to undertake a comprehensive study covering sexual dysfunction in women with RA. The study shows that RA has a significant effect on the sexuality of women, compared to healthy individuals.

Disclosure of Interest R. Puchner Grant/research support from: unrestricted industrial grant Pfizer Austria WI205954, J. Sautner: None declared, J. Gruber: None declared, A. Trenkler: None declared, E. Bragagna: None declared, G. Eberl: None declared, A. Alkin: None declared, H. Pieringer: None declared

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.